Study sheds light on causes of HI...( December 3 2008 (BRONX NY) A new s...),Health
December 3, 2008 (BRONX, NY) A new study led by researchers at Albert Einstein College of Medicine of Yeshiva University has clarified how two major variants of HIV differ in their ability to cause neurologic complications. The finding, published in Journal of Neuroscience, highlights a new target for drugs that could prevent HIV-associated dementia, an incurable and increasingly common complication in people with AIDS. Even with anti-retroviral drug therapies, up to one-half of people infected with HIV will develop mild to moderate neurological complications, according to some estimates.
Earlier this decade, scientists observed that people with AIDS in India developed dementia at a far lower rate than comparable populations in the U.S. and Western Europe. Most cases of AIDS in India are due to infection with a subtype or clade of HIV, known as clade C, while most cases in the U.S. and Western Europe are due to clade B.
Based on these observations, in 2004, a team of researchers led by Dr. Vinayaka R. Prasad, professor of microbiology and immunology at Einstein, began searching for genetic variations between the two clades that could explain the differing rates of HIV-related dementia. The team, in collaboration with Dr. Udaykumar Ranga of the Jawaharlal Nehru Centre for Advanced Scientific Research in Bangalore, India, focused their search on Tat, a protein that helps HIV replicate and leads the attack on the brain.
Dr. Prasad and colleagues compared the sequences of the Tat protein of the two clades and noted a key difference. Where the clade B Tat protein contained the amino acid cysteine at a specific position in the Tat protein, the clade C Tat had the amino acid serine. The next step, and the focus of the current study, was to compare the two viruses in a single host to determine whether this key change in the amino acid sequence makes a practical difference in HIV's neurotoxicity.
To find out, the researc
'/>"/>
| Contact: Michael Heller mheller@aecom.yu.edu 718-430-3101 Albert Einstein College of Medicine Source:Eurekalert |
Related medicine news :
1. Study shows school-based program enables children and adolescents to better manage chronic disease
2. International study supports new standard of treatment for women with advanced ovarian cancer
3. Adult survivors of childhood leukemia have lower bone mineral density, study finds
4. Another Study Warns of Risk From Cardiac Surgery Drug
5. First study to examine rare injuries and conditions of US high school athletes
6. Old as you want to be: Study finds most seniors feel younger
7. Bridging the Technology Gap: Study Confirms Teens Open to Discussing Drugs and Alcohol With Parents By Email, Cell Phones
8. Eisai Will Initiate First Head-to-Head Study Comparing Dacogen(R) (decitabine for injection) and Vidaza(R) (azacitidine) in Patients with Myelodysplastic Syndromes
9. Large study illustrates cardiac CT can effectively assess coronary artery disease
10. MRSA and C. difficile Infections Reduced by 50% in Hospital Study
11. Nationwide study confirms PET as the most powerful imaging tool in cancer management
 Study sheds light on causes of HIV dementia |
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |